NF-κB activity has the impact of enhancing the development of cancer cells, inhibiting cell death, and promoting the creation of new blood vessels by triggering a process called epithelial–mesenchymal transition, which in turn accelerates the spread of cancer to distant parts of the body. Here, NFKB1 is linked to cancer.